Association of glucocorticoid doses and emotional health in lupus low disease activity state (LLDAS): a cross-sectional study.
Yoshia MiyawakiSayaka ShimizuYusuke OgawaKen-Ei SadaYu KatayamaYosuke AsanoKeigo HayashiYuriko YamamuraSumie Hiramatsu-AsanoKeiji OhashiMichiko MorishitaHaruki WatanabeMariko Takano-NarazakiYoshinori MatsumotoNobuyuki YajimaRyusuke YoshimiYasuhiro ShimojimaShigeru OhnoHiroshi KajiyamaKunihiro IchinoseShuzo SatoMichio FujiwaraHajime YamazakiYosuke YamamotoJun WadaShunichi FukuharaPublished in: Arthritis research & therapy (2021)
Daily glucocorticoid doses were inversely associated with emotional health among SLE patients in LLDAS. Further studies are needed to determine whether glucocorticoid tapering leads to clinically significant improvements in emotional health.
Keyphrases
- disease activity
- systemic lupus erythematosus
- public health
- healthcare
- rheumatoid arthritis
- mental health
- rheumatoid arthritis patients
- health information
- end stage renal disease
- ankylosing spondylitis
- physical activity
- newly diagnosed
- ejection fraction
- health promotion
- risk assessment
- prognostic factors
- social media
- peritoneal dialysis
- risk factors
- climate change
- patient reported outcomes